Accelerating Access to Critical Therapies for ALS Act
Latest action · Oct 26, 2020 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 26, 2020
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Accelerating Access to Critical Therapies for ALS Act
This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.
The Department of Health and Human Services (HHS) shall award grants to eligible entities to support research on and facilitate access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases.
HHS shall also establish the Collaborative for Neurodegenerative Diseases, which shall support the development and regulatory approval of drugs that address ALS and other rare neurodegenerative diseases.
Cosponsors 15
Members who signed on, in the order they did. Signatures ran from Oct 26, 2020 to Dec 30, 2020, with 1 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-AK | Lisa Murkowski | Original | Oct 26, 2020 |
| D-NH | Jeanne Shaheen | Nov 30, 2020 | |
| R-AR | John Boozman | Nov 30, 2020 | |
| I-ME | Angus S. King Jr. | Dec 3, 2020 | |
| R-WV | Shelley Moore Capito | Dec 3, 2020 | |
| R-GA | Kelly Loeffler | Dec 10, 2020 | |
| D-NY | Kirsten E. Gillibrand | Dec 10, 2020 | |
| D-CA | Dianne Feinstein | Dec 16, 2020 | |
| R-ND | Kevin Cramer | Dec 16, 2020 | |
| D-AL | Doug Jones | Dec 21, 2020 | |
| I-WV | Joe Manchin III | Dec 21, 2020 | |
| R-ND | John Hoeven | Dec 21, 2020 | |
| D-VT | Patrick J. Leahy | Dec 21, 2020 | |
| R-KS | Jerry Moran | Dec 30, 2020 | |
| D-AZ | Kyrsten Sinema | Dec 30, 2020 |
Actions 2
Everything that happened, newest first.
- Oct 26, 2020Introduced in Senate
- Oct 26, 2020Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Advisory bodies
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Government information and archives
- Health
- Health care coverage and access
- Health care quality
- Health information and medical records
- Health programs administration and funding
- Health promotion and preventive care
- Medical research
- Medical tests and diagnostic methods
- Neurological disorders
- Public contracts and procurement
- Research administration and funding
- Research and development
Text 1
Each version as it was printed, newest first.
- Oct 26, 2020Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.